微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.68% | -0.18% | -2.86% | 91/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 38.79% | -6.82% | -0.94% | 93/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 39.15% | -8.63% | -0.64% | 95/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 39.41% | -10.97% | 4.4% | 96/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 37.74% | -14.56% | -9.32% | 92/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 41.62% | -4.59% | -2.86% | 93/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 42.85% | 0.05% | -3.19% | 87/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 44.26% | -0.95% | 0.2% | 86/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 44.17% | -3.1% | 1.25% | 83/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 43.63% | -20.85% | 1.86% | 86/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 42.83% | -24.55% | -4.15% | 84/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 44.69% | -20.8% | -1.98% | 82/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 45.59% | 2% | -17.3% | 75/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 55.12% | 17.6% | -2.9% | 78/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 56.76% | 2% | 0.61% | 65/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 56.42% | 20.16% | 20.37% | 70/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 46.87% | -9.47% | -0.17% | 93/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 46.96% | 2% | -9.31% | 84/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 51.78% | 3.22% | 3.22% | 68/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 50.16% | -0.38% | -0.38% | 63/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 50.36% | 2% | 2% | 60/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |